Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
Sci Rep ; 7(1): 13189, 2017 10 13.
Article in English | MEDLINE | ID: mdl-29030569

ABSTRACT

Wnt-ß-catenin signalling is essential for skeletal muscle myogenesis during development, but its role in adult human skeletal muscle remains unknown. Here we have used human primary CD56Pos satellite cell-derived myogenic progenitors obtained from healthy individuals to study the role of Wnt-ß-catenin signalling in myogenic differentiation. We show that dephosphorylated ß-catenin (active-ß-catenin), the central effector of the canonical Wnt cascade, is strongly upregulated at the onset of differentiation and undergoes nuclear translocation as differentiation progresses. To establish the role of Wnt signalling in regulating the differentiation process we manipulated key nodes of this pathway through a series of ß-catenin gain-of-function (GSK3 inhibition and ß-catenin overexpression) or loss-of-function experiments (dominant negative TCF4). Our data showed that manipulation of these critical pathway components led to varying degrees of disruption to the normal differentiation phenotype indicating the importance of Wnt signalling in regulating this process. We reveal an independent necessity for active-ß-catenin in the fusion and differentiation of human myogenic progenitors and that dominant negative inhibition of TCF4 prevents differentiation completely. Together these data add new mechanistic insights into both Wnt signalling and adult human myogenic progenitor differentiation.


Subject(s)
Cell Differentiation/physiology , Glycogen Synthase Kinase 3 beta/metabolism , Muscle Development/physiology , beta Catenin/metabolism , Cell Differentiation/genetics , Cells, Cultured , Glycogen Synthase Kinase 3 beta/genetics , Humans , Muscle Development/genetics , Stem Cells/cytology , Stem Cells/metabolism , beta Catenin/genetics
2.
Dev Biol ; 371(2): 203-14, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-23009899

ABSTRACT

The cranial base exerts a supportive role for the brain and includes the occipital, sphenoid and ethmoid bones that arise from cartilaginous precursors in the early embryo. As the occipital bone and the posterior part of the sphenoid are mesoderm derivatives that arise in close proximity to the notochord and floor plate, it has been assumed that their development, like the axial skeleton, is dependent on Sonic hedgehog (Shh) and modulation of bone morphogenetic protein (Bmp) signalling. Here we examined the development of the cranial base in chick and mouse embryos to compare the molecular signals that are required for chondrogenic induction in the trunk and head. We found that Shh signalling is required but the molecular network controlling cranial base development is distinct from that in the trunk. In the absence of Shh, the presumptive cranial base did not undergo chondrogenic commitment as determined by the loss of Sox9 expression and there was a decrease in cell survival. In contrast, induction of the otic capsule occurred normally demonstrating that induction of the cranial base is uncoupled from formation of the sensory capsules. Lastly, we found that the early cranial mesoderm is refractory to Shh signalling, likely accounting for why development of the cranial base occurs after the axial skeleton. Our data reveal that cranial and axial skeletal induction is controlled by conserved, yet spatiotemporally distinct mechanisms that co-ordinate development of the cranial base with that of the cranial musculature and the pharyngeal arches.


Subject(s)
Bone and Bones/embryology , Gene Expression Regulation, Developmental , Hedgehog Proteins/metabolism , Signal Transduction , Skull/embryology , Animals , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/metabolism , Bone and Bones/metabolism , Chick Embryo , Chickens , Embryo, Mammalian/metabolism , Hedgehog Proteins/genetics , Mesoderm/metabolism , Mice , Skull/metabolism
3.
Dev Dyn ; 235(3): 826-34, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16425226

ABSTRACT

Members of the fibroblast growth factor (FGF) family and growth and differentiation factor 5 (GDF-5) have been implicated in joint specification, but their roles in subsequent cavity formation are not defined. Cavity formation (cavitation) depends upon limb movement in embryonic chicks and factors involved in joint formation are often identified by their expression at the joint-line. We have sought support for the roles of FGF-2, FGF-4, and GDF-5 in cavitation by defining expression patterns, immunohistochemically, during joint formation and establishing whether these are modified by in ovo immobilisation. We found that FGF-2 exhibited low level nuclear expression in chondrocytes and fibrocartilage cells close to presumptive joints, but showed significantly higher expression levels in cells at, and directly bordering, the forming joint cavity. This high-level joint line FGF-2 expression was selectively diminished in immobilised limbs. In contrast, we show that FGF-4 does not exhibit differential joint-line expression and was unaffected by immobilisation. GDF-5 protein also failed to show joint-line selective labelling, and although immobilisation induced a cartilaginous fusion across presumptive joints, it did not affect cellular GDF-5 expression patterns. Examining changes in GDF-5 expression in response to a direct mechanical strain stimulus in primary embryonic chick articular surface (AS) cells in vitro discloses only small mechanically-induced reductions in GDF-5 expression, suggesting that GDF-5 does not exert a direct positive contribution to the mechano-dependent joint cavitation process. This notion was supported by retroviral overexpression of UDPGD, a characteristic factor involved in hyaluronan (HA) accumulation at presumptive joint lines, which was also found to produce small decreases in AS cell GDF-5 expression. These findings support a direct mechano-dependent role for FGF-2, but not FGF-4, in the cavitation process and indicate that GDF-5 is likely to influence chondrogenesis positively without contributing directly to joint cavity formation.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Chondrogenesis , Fibroblast Growth Factor 2/metabolism , Fibroblast Growth Factor 4/metabolism , Joints/embryology , Animals , Bone Morphogenetic Proteins/analysis , Bone Morphogenetic Proteins/genetics , Chick Embryo , Chondrocytes/chemistry , Chondrogenesis/genetics , Down-Regulation , Fibroblast Growth Factor 2/analysis , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 4/analysis , Fibroblast Growth Factor 4/genetics , Growth Differentiation Factor 5 , Immobilization , Joints/chemistry , Joints/metabolism , Ovum/cytology , Ovum/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , Stress, Mechanical
4.
Adv Anat Embryol Cell Biol ; 169: III-VI, 1-138, 2003.
Article in English | MEDLINE | ID: mdl-12793205

ABSTRACT

The molecular cascades that control craniofacial development have until recently been little understood. The paucity of data that exists has in part been due to the complexity of the head, which is the most intricate regions of the body. However, the generation of mouse mutants and the identification of gene mutations that cause human craniofacial syndromes, together with classical embryological approaches in other species, have given significant insight into how the head develops. These studies have emphasized how unique the head actually is, with each individual part governed by a distinct set of signalling interactions, again demonstrating the complexity of this region of the body. This review discussed the tissue and molecular interactions that control each region of the head. The processes that control neural tube closure together with correct development of the skull, midline patterning, neural crest generation and migration, outgrowth, patterning, and differentiation of the facial primordia and the branchial arches are thus discussed. Defects in these processes result in a number of human syndromes such as exencephaly, holoprosencephaly, musculoskeletal dysplasias, first arch syndromes such as Riegers and Treacher-Collins syndrome, and neural crest dysplasias such as DiGeorge syndrome. Our current knowledge of the genes responsible for these human syndromes together with how the head develops, is rapidly advancing so that we will soon understand the complex set of molecular and tissue interactions that build a head.


Subject(s)
Face/embryology , Face/physiology , Head/embryology , Animals , Body Patterning/genetics , Branchial Region/embryology , DiGeorge Syndrome/embryology , DiGeorge Syndrome/genetics , Genes, Homeobox/physiology , Growth Substances/physiology , Holoprosencephaly/embryology , Holoprosencephaly/genetics , Humans , Mandibulofacial Dysostosis/embryology , Mandibulofacial Dysostosis/genetics , Mesoderm/physiology , Neural Crest/cytology , Neural Crest/physiology , Signal Transduction , Skull/embryology
6.
Semin Arthritis Rheum ; 31(1): 33-42, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11503137

ABSTRACT

OBJECTIVES: To review current knowledge of the role of bone morphogenetic proteins (BMPs) in joint formation and how this may be relevant to healing in adult joints. METHOD: Review of published literature using a search of the PubMed database (1966 to 2000) made available by the National Library of Medicine. Additional articles of historical interest were identified from the bibliographies of published literature. RESULTS: BMPs and a related family, the growth and differentiation factors (GDFs), are stimulators of bone and cartilage formation in the developing skeleton. They, together with their antagonists, play key roles in the specification of the joint site and cavitation of synovial joints during embryonic development. Disruption of the GDF-5 gene in mice and humans is associated with abnormal joint formation. In situ hybridization studies have shown that BMPs are expressed during formation of synovial joints in the embryo. However, excessive BMP activity leads to obliteration of joints because of cartilage overgrowth. BMPs are being considered as therapeutic agents to stimulate healing of articular cartilage after damage. Evidence suggests that BMPs are present in adult joints and have roles in healing and maintenance. However, inflammatory cytokines and growth factors present in damaged joints modulate the actions of BMPs. CONCLUSIONS: BMPs, and in particular GDF-5, are involved in synovial joint formation. They may also have effects on the maintenance and healing of adult joints, but factors present after damage may alter their effectiveness. RELEVANCE: Articular cartilage heals poorly after damage. BMPs may be useful therapeutically to stimulate healing of damaged articular cartilage. Increased knowledge of their role in joint formation will improve understanding of how to use them. Semin Arthritis Rheum 31:33-42.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Joints/metabolism , Synovial Membrane/metabolism , Wound Healing/physiology , Animals , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/pharmacology , Cartilage, Articular/embryology , Cartilage, Articular/injuries , Cartilage, Articular/metabolism , Disease Models, Animal , Growth Differentiation Factor 5 , Growth Substances/genetics , Growth Substances/metabolism , Humans , Joint Diseases/physiopathology , Joint Diseases/therapy , Joints/embryology , Joints/injuries , Mice , Point Mutation , Synovial Membrane/embryology , Wound Healing/drug effects
7.
Dev Biol ; 235(1): 98-109, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11412030

ABSTRACT

BMP-2 and BMP-4 are known to be involved in the early events which specify the cardiac lineage. Their later patterns of expression in the developing mouse and chick heart, in the myocardium overlying the atrioventricular canal (AV) and outflow tract (OFT) cushions, also suggest that they may play a role in valvoseptal development. In this study, we have used a recombinant retrovirus expressing noggin to inhibit the function of BMP-2/4 in the developing chick heart. This procedure resulted in abnormal development of the OFT and the ventricular septum. A spectrum of abnormalities was seen ranging from common arterial trunk to double outlet right ventricle. In hearts infected with noggin virus, where the neural crest cells have been labelled, the results show that BMP-2/4 function is required for the migration of neural crest cells into the developing OFT to form the aortopulmonary septum. Prior to septation, misexpression of noggin also leads to a decrease in the number of proliferating mesenchymal cells within the proximal cushions of the outflow tract. These results suggest that BMP-2/4 function may mediate several key events during cardiac development.


Subject(s)
Heart Septal Defects/etiology , Heart/embryology , Proteins/genetics , Transforming Growth Factor beta , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/physiology , Carrier Proteins , Cell Division/physiology , Chick Embryo , In Situ Hybridization , Myocardium/metabolism , Neural Crest/cytology , Phenotype
8.
J Bone Joint Surg Am ; 83-A Suppl 1(Pt 1): S23-30, 2001.
Article in English | MEDLINE | ID: mdl-11263662

ABSTRACT

BACKGROUND: Growth/differentiation factor-5 (GDF-5) has been shown to be essential for normal appendicular skeletal and joint development in humans and mice. In brachypod, a Gdf-5 gene mouse mutant, the defect is first apparent during early chondrogenesis, with the cartilage blastema already reduced in size by E12.5. This defect is associated with changes in the expression of cell surface molecules. METHODS: To understand further how GDF-5 controls cartilage formation, we first mapped the expression of the Gdf-5 gene during skeletal development (please note that the abbreviation for the gene is given in italics and the abbreviation for the protein expressed by the gene is given in capital letters). Subsequently, we over-expressed GDF-5 in the developing chick embryo using a replication competent retrovirus, RCAS(BP). We determined its effects on skeletal development by histological examination and its effects on early growth by autoradiography of proliferating cells. In addition, we examined the effect of GDF-5 on chondrogenic differentiation using micromass and single cell suspension cultures of limb mesenchymal cells, RESULTS: These studies show that the Gdf-5 gene is expressed in the early cartilage condensation, the perichondrium, and the joint interzone. Over-expresSion of GDF-5 in chick limb buds, during the condensation stage or later when the skeletal elements have formed, increased the size of the affected elements. In both cases, the increase in size was associated with an increase in cell number and, at later stages, this was correlated with an increase in S-phase cells. In vitro studies showed that GDF-5 could increase cell adhesiveness, and this may be a mechanism through which GDF-5 initiates condensation formation. CONCLUSION: These studies show that GDF-5 acts at two stages of skeletal development and by two distinct mechanisms. First, GDF-5 promotes the initial stages of chondrogenesis by promoting cell adhesion, which is consistent with the expression of Gdf-5 in the cartilage condensation. Second, GDF-5 can increase the size of the skeletal elements by increasing proliferation within the epiphyseal cartilage adjacent to its expression within the joint interzone.


Subject(s)
Bone Development/physiology , Bone Morphogenetic Proteins , Gene Expression , Growth Substances/physiology , Animals , Bone Development/genetics , Cell Adhesion , Cell Division , Cells, Cultured , Growth Differentiation Factor 5 , Humans , Mutation
9.
Science ; 290(5498): 1965-7, 2000 Dec 08.
Article in English | MEDLINE | ID: mdl-11110663

ABSTRACT

Tissue manipulation experiments in amphibians more than 50 years ago showed that induction of the inner ear requires two signals: a mesodermal signal followed by a neural signal. However, the molecules mediating this process have remained elusive. We present evidence for mesodermal initiation of otic development in higher vertebrates and show that the mesoderm can direct terminal differentiation of the inner ear in rostral ectoderm. Furthermore, we demonstrate the synergistic interactions of the extracellular polypeptide ligands FGF-19 and Wnt-8c as mediators of mesodermal and neural signals, respectively, initiating inner ear development.


Subject(s)
Ear, Inner/embryology , Embryonic Induction , Fibroblast Growth Factors/metabolism , Mesoderm/metabolism , Proto-Oncogene Proteins/metabolism , Zebrafish Proteins , Animals , Central Nervous System/embryology , Central Nervous System/metabolism , Chick Embryo , Culture Techniques , Ear, Inner/metabolism , Ectoderm/cytology , Fibroblast Growth Factor 3 , Fibroblast Growth Factors/genetics , Fibroblast Growth Factors/pharmacology , Gene Expression , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , In Situ Hybridization , Molecular Sequence Data , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/pharmacology , Quail/embryology , Rhombencephalon/embryology , Rhombencephalon/metabolism , Signal Transduction , Wnt Proteins
10.
Development ; 127(24): 5285-95, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11076751

ABSTRACT

In the avian hindbrain, the loss of premigratory neural crest cells from rhombomeres 3 and 5 (r3, r5) through programmed cell death contributes to the patterning of emigrant crest cells into three discrete streams. Programmed cell death is induced by the upregulation of Bmp4 and Msx2 in r3 and r5. We show that cSFRP2, a WNT antagonist, is expressed in the even-numbered rhombomeres and that over-expression of cSfrp2 inhibits Bmp4 expression in r3 and r5, preventing programmed cell death. By contrast, depleting cSFRP2 function in r4 results in elevated levels of Msx2 expression and ectopic programmed cell death, as does overexpression of Wnt1. We propose that programmed cell death in the rhombencephalic neural crest is modulated by pre-patterned cSfrp2 expression and a WNT-BMP signalling loop.


Subject(s)
Apoptosis/physiology , Proteins/physiology , Proto-Oncogene Proteins/antagonists & inhibitors , Rhombencephalon/embryology , Rhombencephalon/metabolism , Zebrafish Proteins , Animals , Base Sequence , Bone Morphogenetic Protein 4 , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/physiology , Chick Embryo , DNA Primers/genetics , Gene Expression Regulation, Developmental , In Situ Hybridization , Models, Neurological , Neural Crest/cytology , Neural Crest/embryology , Neural Crest/metabolism , Proteins/genetics , Rhombencephalon/cytology , Wnt Proteins , Wnt1 Protein
11.
Proc Natl Acad Sci U S A ; 97(18): 10044-9, 2000 Aug 29.
Article in English | MEDLINE | ID: mdl-10954731

ABSTRACT

Teeth have been missing from birds (Aves) for at least 60 million years. However, in the chick oral cavity a rudiment forms that resembles the lamina stage of the mammalian molar tooth germ. We have addressed the molecular basis for this secondary loss of tooth formation in Aves by analyzing in chick embryos the status of molecular pathways known to regulate mouse tooth development. Similar to the mouse dental lamina, expression of Fgf8, Pitx2, Barx1, and Pax9 defines a potential chick odontogenic region. However, the expression of three molecules involved in tooth initiation, Bmp4, Msx1, and Msx2, are absent from the presumptive chick dental lamina. In chick mandibles, exogenous bone morphogenetic protein (BMP) induces Msx expression and together with fibroblast growth factor promotes the development of Sonic hedgehog expressing epithelial structures. Distinct epithelial appendages also were induced when chick mandibular epithelium was recombined with a tissue source of BMPs and fibroblast growth factors, chick skin mesenchyme. These results show that, although latent, the early signaling pathways involved in odontogenesis remain inducible in Aves and suggest that loss of odontogenic Bmp4 expression may be responsible for the early arrest of tooth development in living birds.


Subject(s)
Nuclear Proteins , Odontogenesis/physiology , Signal Transduction/physiology , Animals , Bone Morphogenetic Protein 4 , Bone Morphogenetic Proteins/genetics , Chick Embryo , Chickens , DNA-Binding Proteins/genetics , Fibroblast Growth Factor 8 , Fibroblast Growth Factors/genetics , Homeodomain Proteins/genetics , MSX1 Transcription Factor , Mandible/embryology , Mice , Mice, Mutant Strains , Morphogenesis , Natal Teeth/embryology , PAX9 Transcription Factor , Paired Box Transcription Factors , Transcription Factors/genetics , Homeobox Protein PITX2
12.
Dev Biol ; 218(2): 183-98, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10656762

ABSTRACT

The Wnt genes are known to play fundamental roles during patterning and development of a number of embryonic structures. Receptors for Wnts are members of the Frizzled family of proteins containing a cysteine-rich domain (CRD) that binds the Wnt protein. Recently several secreted frizzled-related proteins (Sfrps) that also contain a CRD have been identified and some of these can both bind and antagonise Wnt proteins. In this paper we report the expression patterns of the chick homologues of Frzb, a known Wnt antagonist, and Sfrp-2. Both genes are expressed in areas where Wnts are known to play a role in development, including the neural tube, myotome, cartilage, and sites of epithelial-mesenchymal interactions. Initially, Sfrp-2 and Frzb are expressed in overlapping areas in the neural plate and neural tube, whereas later, they have distinct patterns. In particular Sfrp-2 is associated with myogenesis while Frzb is associated with chondrogenesis, suggesting that they play different roles during development. Finally, we have used the early Xenopus embryo as an in vivo assay to show that Sfrp-2, like Frzb, is a Wnt antagonist. These results suggest that Sfrp-2 and Frzb may function in the developing embryo by modulating Wnt signalling.


Subject(s)
Eye Proteins/genetics , Glycoproteins , Proteins/genetics , Zebrafish Proteins , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Chick Embryo , Cloning, Molecular , DNA Primers , Embryonic Development , Intracellular Signaling Peptides and Proteins , Molecular Sequence Data , Proto-Oncogene Proteins/antagonists & inhibitors , Sequence Homology, Amino Acid , Wnt Proteins , Xenopus
13.
Int J Dev Biol ; 43(6): 495-500, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10610022

ABSTRACT

In developing limb bud, mesenchymal cells form cellular aggregates called "mesenchymal condensations". These condensations show the prepattern of skeletal elements of the limb prior to cartilage differentiation. Roles of various signaling molecules in chondrogenesis in the limb bud have been reported. One group of signaling factors includes the Wnt proteins, which have been shown to have an inhibitory effect on chondrogenesis in the limb bud. Therefore, regulation of Wnt activity may be important in regulating cartilage differentiation. Here we show that Frzb-1, which encodes a secreted frizzled-related protein that can bind to Wnt proteins and can antagonize the activity of some Wnts, is expressed in the developing limb bud. At early stages of limb development, Frzb-1 is expressed in the ventral core mesenchyme of the limb bud, and later Frzb-1 expression becomes restricted to the central core region where mesenchymal condensations occur. At these stages, a chondrogenic marker gene, aggrecan, is not yet expressed. As limb development proceeds, expression of Frzb-1 is detected in cartilage primordial cells, although ultimately Frzb-1 expression is down-regulated. Similar results were obtained in the recombinant limb bud, which was constructed from dissociated and re-aggregated mesenchymal cells and an ectodermal jacket with the apical ectodermal ridge. In addition, Frzb-1 expression preceded aggrecan expression in micromass cultures. These results suggest that Frzb-1 has a role in condensation formation and cartilage differentiation by regulating Wnt activity in the limb bud.


Subject(s)
Cartilage/metabolism , Extracellular Matrix Proteins , Glycoproteins , Mesoderm/metabolism , Proteins/metabolism , Zebrafish Proteins , Aggrecans , Animals , Cartilage/embryology , Cells, Cultured , Chick Embryo , Chondrogenesis/genetics , Gene Expression Regulation, Developmental , In Situ Hybridization , Intracellular Signaling Peptides and Proteins , Lectins, C-Type , Limb Buds , Mesoderm/cytology , Microscopy, Phase-Contrast , Proteins/genetics , Proteoglycans/genetics , Proteoglycans/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Wnt Proteins
15.
Genomics ; 59(2): 203-12, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10409432

ABSTRACT

Wolf-Hirschhorn syndrome (WHS) is a multiple malformation syndrome characterized by mental and developmental defects resulting from the absence of a segment of one chromosome 4 short arm (4p16.3). Recently, Pitt-Rogers-Danks syndrome (PRDS), which is also due to a deletion of chromosome 4p16.3, has been shown to be allelic to WHS. Due to the complex and variable expression of these disorders, it is thought that WHS/PRDS results from a segmental aneusomy of 4p resulting in haploinsufficieny of an undefined number of genes that contribute to the phenotype. In an effort to identify genes that contribute to human development and whose absence may contribute to the phenotype associated with these syndromes, we have generated a transcript map of the 165-kb critical region and have identified a number of potential genes. One of these genes, WHSC2, which was identified with the IMAGE cDNA clone 53283, has been characterized. Sequence analysis defined an open reading frame of 1584 bp (528 amino acids), and transcript analysis detected a 2.4-kb transcript in all fetal and adult tissues tested. In parallel, the mouse homologue was isolated and characterized. Mouse sequence analysis and the pattern of expression are consistent with the clone being the murine equivalent of the human WHSC2 gene (designated Whsc2h). The data from sequence and transcript analysis of this new human gene in combination with the lack of significant similarity to proteins of known function imply that it represents a novel gene. Most importantly, its location within the WHSCR suggests that this gene may play a role in the phenotype of the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome.


Subject(s)
Chromosomes, Human, Pair 4/genetics , Genes/genetics , Growth Disorders/genetics , Intellectual Disability/genetics , Proteins/genetics , 3' Untranslated Regions , 5' Untranslated Regions , Adult , Amino Acid Sequence , Animals , Base Sequence , DNA, Complementary/chemistry , DNA, Complementary/genetics , Embryo, Mammalian/metabolism , Embryonic and Fetal Development , Exons , Female , Gene Expression , Gene Expression Regulation, Developmental , Humans , In Situ Hybridization , Introns , Male , Mice , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Syndrome , Tissue Distribution , Transcription, Genetic , Transcriptional Elongation Factors
16.
Dev Dyn ; 214(4): 291-302, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10213385

ABSTRACT

The vertebrate face develops from a series of primordia surrounding the primitive mouth and is thought to be patterned by the differential expression of homeobox-containing genes. Here we describe the isolation of the chick homologue of the homeobox-containing gene, Barx-1, and show its expression in the developing facial primordia, stomach, and appendicular skeleton. In the maxillary primordia, mesenchymal expression of Barx-1 is complementary to that of Msx-1, which correlate with overlying epithelial expression of Fgf-8 and Bmp-4, respectively. We show that epithelial signals are required to maintain Barx-1 expression and that FGF-8 can substitute for the epithelium. By contrast, BMPs reduce Barx-1 expression and can antagonize FGF-8 signaling. This suggests that in vivo, FGF-8/BMP signaling may regulate Barx-1 gene expression. This provides evidence that the differential expression of FGF-8 and BMPs may determine homeobox-containing gene expression and hence patterning of the facial primordia.


Subject(s)
Bone Morphogenetic Proteins/genetics , Fibroblast Growth Factors/genetics , Homeodomain Proteins/metabolism , Maxilla/embryology , Transcription Factors/metabolism , Amino Acid Sequence , Animals , Blotting, Northern , Bone and Bones/embryology , Chick Embryo , Cloning, Molecular , Embryo, Mammalian/anatomy & histology , Embryo, Mammalian/metabolism , Face/embryology , Fibroblast Growth Factor 8 , Gene Expression Regulation, Developmental , In Situ Hybridization , MSX1 Transcription Factor , Mice , Molecular Sequence Data , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
17.
Cell Tissue Res ; 296(1): 111-9, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10199971

ABSTRACT

The synovial joint arises from an initial condensation of cells that subsequently develops into distinct skeletal structures, separated by the joint. Bone morphogenetic proteins (BMPs) and growth and differentiation factors (GDFs) have a fundamental role during skeletogenesis, including joint formation. Development of the joint appears to be dependent on the differential expression/activity of the related BMP and GDF subfamilies. Gdf-5 is expressed in the developing joints and is necessary for the formation of some joints. In contrast, recent data has shown that antagonism of the BMP family is crucial for joint formation. Here, we review mechanisms of how BMP signalling may be antagonised/modified. We also describe the expression of Bmp-2 and Bmp-4 together with two BMP antagonists, chordin and noggin, during chick joint development. Finally, we discuss possible mechanisms of how a joint forms and the evidence that the joint is a 'signalling centre' that may coordinate the development of adjacent skeletal structures.


Subject(s)
Bone Morphogenetic Proteins/physiology , Growth Substances/physiology , Joints/embryology , Synovial Membrane/embryology , Animals , Body Patterning , Bone Morphogenetic Proteins/genetics , Cartilage, Articular/embryology , Cell Differentiation , Chick Embryo , Epidermal Growth Factor/physiology , Fibroblast Growth Factors/physiology , Gene Expression Regulation, Developmental , Signal Transduction
18.
Development ; 126(6): 1305-15, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10021348

ABSTRACT

Mutations in GDF-5, a member of the TGF-beta superfamily, result in the autosomal recessive syndromes brachypod (bp) in mice and Hunter-Thompson and Grebe-type chondrodysplasias in humans. These syndromes are all characterised by the shortening of the appendicular skeleton and loss or abnormal development of some joints. To investigate how GDF-5 controls skeletogenesis, we overexpressed GDF-5 during chick limb development using the retrovirus, RCASBP. This resulted in up to a 37.5% increase in length of the skeletal elements, which was predominantly due to an increase in the number of chondrocytes. By injecting virus at different stages of development, we show that GDF-5 can increase both the size of the early cartilage condensation and the later developing skeletal element. Using in vitro micromass cultures as a model system to study the early steps of chondrogenesis, we show that GDF-5 increases chondrogenesis in a dose-dependent manner. We did not detect changes in proliferation. However, cell suspension cultures showed that GDF-5 might act at these stages by increasing cell adhesion, a critical determinant of early chondrogenesis. In contrast, pulse labelling experiments of GDF-5-infected limbs showed that at later stages of skeletal development GDF-5 can increase proliferation of chondrocytes. Thus, here we show two mechanisms of how GDF-5 may control different stages of skeletogenesis. Finally, our data show that levels of GDF-5 expression/activity are important in controlling the size of skeletal elements and provides a possible explanation for the variation in the severity of skeletal defects resulting from mutations in GDF-5.


Subject(s)
Bone Morphogenetic Proteins , Bone and Bones/embryology , Cartilage/embryology , Extremities/embryology , Growth Substances/metabolism , Amino Acid Sequence , Animals , Cell Aggregation/drug effects , Cell Division/drug effects , Chick Embryo , Chondrogenesis/drug effects , Cloning, Molecular , DNA/analysis , Glycosaminoglycans/analysis , Growth Differentiation Factor 5 , Growth Substances/genetics , Growth Substances/pharmacology , Humerus/chemistry , Limb Buds/embryology , Molecular Sequence Data , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid
19.
Mech Dev ; 75(1-2): 3-28, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9739099

ABSTRACT

The development of the vertebrate face is a dynamic multi-step process which starts with the formation of neural crest cells in the developing brain and their subsequent migration to form, together with mesodermal cells, the facial primordia. Signalling interactions co-ordinate the outgrowth of the facial primordia from buds of undifferentiated mesenchyme into the intricate series of bones and cartilage structures that, together with muscle and other tissues, form the adult face. Some of the molecules that are thought to be involved have been identified through the use of mouse mutants, data from human craniofacial syndromes and by expression studies of signalling molecules during facial development. However, the way that these molecules control the epithelial-mesenchymal interactions which mediate facial outgrowth and morphogenesis is unclear. The role of neural crest cells in these processes has also not yet been well defined. In this review we discuss the complex interaction of all these processes during face development and describe the candidate signalling molecules and their possible target genes.


Subject(s)
Embryonic and Fetal Development/physiology , Face/embryology , Face/physiology , Animals , Embryonic and Fetal Development/genetics , Gene Expression Regulation, Developmental , Genes/genetics , Humans , Signal Transduction/physiology
20.
Dev Biol ; 196(1): 11-23, 1998 Apr 01.
Article in English | MEDLINE | ID: mdl-9527877

ABSTRACT

The formation of periodic patterns is fundamental in biology. Theoretical models describing these phenomena have been proposed for feather patterning; however, no molecular candidates have been identified. Here we show that the feather tract is initiated by a continuous stripe of Shh, Fgf-4, and Ptc expression in the epithelium, which then segregates into discrete feather primordia that are more strongly Shh and Fgf-4 positive. The primordia also become Bmp-2 and Bmp-4 positive. Bead-mediated delivery of BMPs inhibits local feather formation in contrast with the activators, SHH and FGF-4, which induce feather formation. Both FGF-4 and SHH induce local expression of Bmp-4, while BMP-4 suppresses local expression of both. FGF-4 also induces Shh. Based on these findings, we propose a model that involves (1) homogeneously distributed global activators that define the field, (2) a position-dependent activator of competence that propagates across the field, and (3) local activators and inhibitors triggered in sites of individual primordia that act in a reaction-diffusion mechanism. A computer simulation model for feather pattern formation is also presented.


Subject(s)
Body Patterning , Bone Morphogenetic Proteins/pharmacology , Feathers/embryology , Skin/embryology , Trans-Activators , Transforming Growth Factor beta , Animals , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Chick Embryo , Dose-Response Relationship, Drug , Factor IX/metabolism , Fibroblast Growth Factor 4 , Fibroblast Growth Factors/metabolism , Gene Expression Regulation, Developmental , Hedgehog Proteins , Models, Biological , Periodicity , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...